CLARKE JOHN K 4
4 · aTYR PHARMA INC · Filed May 10, 2019
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
CLARKE JOHN K
DirectorOther
Transactions
- Award
Stock Option (right to buy)
2019-05-08+20,000→ 20,000 totalExercise: $0.58Exp: 2029-05-08→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.